Results

Total Results: 1,313 records

Showing results for "size".

101. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
     March 01, 2022 - (N Studies) [SOE] Pain Severity Effect Size (N Studies) [SOE] Function Effect Size (N Studies … (N Studies) [SOE] SAE Effect Size (N Studies) [SOE] Dizziness Effect Size (N Studies) [SOE … ] Nausea Effect Size (N Studies) [SOE] Sedation Effect Size (N Studies) [SOE] Comparable … (N Studies) [SOE] SAE Effect Size (N Studies) [SOE] Dizziness Effect Size (N Studies) [SOE … ] Nausea Effect Size (N Studies) [SOE] Sedation Effect Size (N Studies) [SOE] Low THC – Topical

102. Can Physical Activity Improve the Health of Wheelchair Users? Amended Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-users-amended-protocol.pdf
     June 21, 2019 - Sample size, clarification of specific interventions and outcomes for inclusion or exclusion, and the … These decisions regarding study design, study size, publication date range, and prioritization of outcomes … abstracted data will include, but are not limited to: study design, year, setting, country, sample size … The revised protocol will indicate a new minimum sample size for included studies of the SCI population … Changing the sample size for SCI studies to n=20 increases the number of includable SCI studies

103. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
     January 01, 2021 - 0.03 LAI: 11.4 (4.6) vs. 12.5 (4.6), MD −1.10 (95% CI −3.11 to 0.89), p=0.277, Cohen's d effect size … NPS during TUG: 3.1 (2.8) vs. 3.5 (2.9), MD −0.42 (95% CI −1.65 to 0.80), p=0.497, Cohen's d effect size … 0.07 LAI: 12.2 (4.3) vs. 12.4 (5.3), MD −0.16 (95% CI −2.15 to 1.81), p=0.869, Cohen's d effect size … -0.39 LAI: 10.2 (4.6) vs. 12.5 (4.6), MD −2.30 (95% CI −4.30 to −0.29), p=0.025, Cohen's d effect size … -0.40 LAI: 8.2 (3.9) vs. 12.4 (5.3), MD −4.19 (95 % CI −6.18 to −2.21), p<0.001, Cohen's d effect size

104. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
     January 01, 2021 - 0.03 LAI: 11.4 (4.6) vs. 12.5 (4.6), MD −1.10 (95% CI −3.11 to 0.89), p=0.277, Cohen's d effect size … NPS during TUG: 3.1 (2.8) vs. 3.5 (2.9), MD −0.42 (95% CI −1.65 to 0.80), p=0.497, Cohen's d effect size … 0.07 LAI: 12.2 (4.3) vs. 12.4 (5.3), MD −0.16 (95% CI −2.15 to 1.81), p=0.869, Cohen's d effect size … -0.39 LAI: 10.2 (4.6) vs. 12.5 (4.6), MD −2.30 (95% CI −4.30 to −0.29), p=0.025, Cohen's d effect size … -0.40 LAI: 8.2 (3.9) vs. 12.4 (5.3), MD −4.19 (95 % CI −6.18 to −2.21), p<0.001, Cohen's d effect size

105. Liver-Cancer Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
     October 01, 2014 - of imaging strategies; they include risk factors for HCC and lesion characteristics, such as tumor size … We also evaluated diagnostic accuracy in subgroups stratified according to HCC lesion size, degree … Lesion size US with contrast Sensitivity: Low Specificity: Low Sensitivity was 0.94 (95% CI, 0.83 … Data were not pooled due to differences in the tumor size categories evaluated. … Two studies of 11C-acetate PET found inconsistent effects of lesion size on sensitivity.

106. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
     September 01, 2012 - Resource use, size, and duration Resource use less than in an RCT but still moderate to high. … Size may be an issue due to low prevalence of PCDs. … Resource use likely to be moderate; sample size would depend on number of respondents. … The feasibility of such studies generally does not depend on the desired sample size. … Size may be an issue due to low prevalence of PCDs.

107. Microsoft Word - Comparative_Effectiveness_Research_Review_Disposition_of_Comments_Report_Final_120710_refs_delinked1.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_disposition-comments.pdf
     November 01, 2010 - With the assistance of our technical experts, we selected a minimum sample size of 10 in order to maximize … This lack of balance may be due in part to the small size of the trial (n=23). … randomize based on their internal methodology and report on this difference within a small sample size … smaller studies, but these studies were not excluded based upon study design but based upon sample size … We have added rationale about our decisions regarding sample size to the Methods section of the review

108. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
     December 01, 2009 - Medical indications—such as size and location of the lesion, imaging characteristics of the lesion, and … The grade was developed after consideration of the quality of the evidence base, the size of the evidence … did not identify a statistically significant effect of the following factors on the results: needle size … of needle Not rated The size of the needle did not affect the accuracy of the procedure Clinician … severe bleeding and hematoma formation Use of image guidance Insufficient No conclusion possible Size

109. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2022 Update of the PTSD-Repository Evidence Base (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-dispositIon-comments-2022.pdf
     January 01, 2022 - the scope of this update, Appendix G provides a detailed example of how to find and compare effect size … The data abstraction, effect size calculation and risk of bias seem reasonable. … The PTSD-Repository is meant to capture all RCTs, regardless of sample size. … A detailed explanation of how to find and use effect size data is available in Appendix G. … The data extraction and effect size calculation processes are clear and appropriate.

110. Kidney-Stones-Draft-Appendi-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
     January 01, 2024 - . (%) Intervention 1 Sample Size Intervention 1 Mean Age (SD) Intervention 1 Women No. (%) Intervention … 1 Race/Ethnicity No. (%) Intervention 2 Sample Size Intervention 2 Mean Age (SD) Intervention 2 Women … No. (%) Intervention 2 Race/Ethnicity No. (%) Intervention 3 Sample Size Intervention 3 Mean Age (SD … Mean Age (SD) Intervention 4 Women No. (%) Intervention 4 Race/Ethnicity No. (%) Intervention 5 Sample Size … defined as >2 mm growth Unchanged stone size defined as <2 mm growth N (%) with unchanged stone size

111. Liver-Cancer Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer_research-protocol.pdf
     July 24, 2013 - Staging of HCC is based on the size and number of lesions and helps to determine appropriate treatments … Sample Size Studies with very small numbers of participants (n < 20) will not be included. … Additional information on lesion size, stages, time limits, and the reference standard used will be … among studies in design, patient population, interventions, and outcomes; and magnitude of effect size … 9. = Not English language but otherwise relevant 10. = Wrong duration of followup 11. = Sample size

112. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/undescended-testicle_research-protocol.pdf
     September 02, 2011 - intervention The effect on infertility/subfertility The development of testicular malignancy The size … intervention The effect on infertility/subfertility The development of testicular malignancy The size … Testicular size and appearance 2. Testicular position 3. Pain 4. … Testicular size and appearance 2. Testicular position 3. Endocrine function 4. … Primary outcomes include testicular size, position, and appearance; parent/patient satisfaction; psychosocial

113. Omega-3 Fatty Acids and Maternal and Child Health: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
     October 01, 2016 - of n-3 FA (WMD 0.07 [0.00, 0.14] six RCTs); the pooled effect size for VEP was insignificant (WMD … At 4 months follow- up, the pooled effect size for behavioral measurements was significant in favor … [-0.04, 0.01]); the pooled effect size for VEP was significant in favor of n-3 FA (WMD -0.14 [-0.17, … Most RCTs were also small in size, although most reported doing power calculations. … Confidence intervals for the overall effect size in random-effects meta-analysis.

114. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
     May 01, 2022 - (N Studies) [SOE] Pain Severity Effect Size (N Studies) [SOE] Function Effect Size (N Studies … (N Studies) [SOE] SAE Effect Size (N Studies) [SOE] Dizziness Effect Size (N Studies) [SOE … ] Nausea Effect Size (N Studies) [SOE] Sedation Effect Size (N Studies) [SOE] Comparable … (N Studies) [SOE] SAE Effect Size (N Studies) [SOE] Dizziness Effect Size (N Studies) [SOE … ] Nausea Effect Size (N Studies) [SOE] Sedation Effect Size (N Studies) [SOE] High THC –

115. Hypertension-Pulmonary-Arterial Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
     April 01, 2013 - Limited data on FAC, RA size, RIMP, RV size, tricuspid lateral annular systolic velocity (S’), and … • Right atrial (RA) size correlates with increased risk of mortality (moderate strength of evidence … These included sPAP (17 studies), RIMP/MPI/ Tei (14), RA size (11), pericardial effusion (11), RV size … RA size was also predictive of mortality. … RA size 4 (242) 1.06 (1.01 to 1.10) SOE = Moderate RA size is a predictor of mortality.

116. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
     December 09, 2009 - reviewed these criteria during the first conference call with the TEP, including discussing varied study size … Based on TEP feedback, we will leave the admissible study size at 10 participants but will review the … implications of that decision in terms of how many studies are excluded simply on size and in which … We will revise the study size criteria, as appropriate, based on the input from the group at that time … publication, study location (e.g., country, city, state) and time period, population description, sample size

117. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
     January 01, 2010 - reviewed these criteria during the first conference call with the TEP, including discussing varied study size … Based on TEP feedback, we will leave the admissible study size at 10 participants but will review the … implications of that decision in terms of how many studies are excluded simply on size and in which … We will revise the study size criteria, as appropriate, based on the input from the group at that time … publication, study location (e.g., country, city, state) and time period, population description, sample size

118. Choice-Of-Mean White-Paper (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/choice-of-mean_white-paper.pdf
     April 01, 2015 - a placebo group, and the intervention group has a worse baseline score; then the treatment effect size … Group #2) Number of Studies (N) Group #1 and Group #2 Total Sample Size (Min-Max) Baseline … Group #2) Number of Studies (N) Group #1 and Group #2 Total Sample Size (Min-Max) Baseline … No other common characteristics relating to the size and number of included studies, type of outcomes … Baseline distribution and conditional size. J Biopharm Stat. 1993 Sep;3(2):265-76.

119. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-brain-injury_research-protocol.pdf
     December 09, 2009 - be abstracted from data presented in the papers Inclusion and exclusion criteria based on study size … The EPC will record the study size of any study that would be excluded only because it has less than … The EPC will then set a study size cut-off based on the number of key or sentinel papers that would … publication, study location (e.g., country, city, state) and time period, population description, sample size

120. Treatment of Stage I-III Squamous Cell Anal Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-protocol.pdf
     September 26, 2023 - Table 1 reports SCC staging, which is based on tumor size/extent.4,7 Anal SCCs are further classified … nodes, and/or external iliac nodes), M0 III T3-T4 (tumor >5cm in greatest dimension or tumor of any size … setting, subject inclusion and exclusion criteria, intervention and control characteristics, sample size … We will assess the clinical and methodological heterogeneity and variation in effect size to determine … r adj2 (diameter or dimension or size or volume)).ti,ab. 100012 12 algorithms/ or disease-free survival